Symborg and Biogard signed an exclusive agreement to develop and market MycoUp in Italy

Symborg and Biogard, a division of CBC (Europe), recently announced that the companies have signed an exclusive agreement to develop and market MycoUp in Italy. MycoUp is a product based on the mycorrhizal forming fungus Glomus iranicum var. tenuihypharum, a unique and patented species only produced by Symborg.

 

Jesús Juárez, Founder and Chief Executive Officer of Symborg, comments: “The enormous potential of microbiology in improving agricultural production without damaging soil sustainability is a reality. Symborg’s products are a natural response to the demands of today’s agriculture. MycoUp avoids the depletion of agricultural soils and improves crop yields with zero impact on the environment. Symborg’s vision is to develop agricultural biotechnology together with the farmers and we wanted to find a national partner in Italy that spreads the same values as Symborg: that is what we found in CBC (Europe) that we are very happy to add to our growing network of strategic partners”.
 

Vittorio Veronelli, CEO of CBC (Europe), “MycoUp and the technology of Symborg are perfectly fitting in the Biogard product portfolio and complete the range of Microbial based products with a unique patented species of mycorrhizal fungus. This agreement strengthens our commitment in the development of green agricultural products and allows Biogard to enter in the market segment of soil inoculants where only high performing products, like MycoUp, can play a key role. Our goal is to introduce in the coming years also different Symborg formulations of mycorrhizal fungus (Resid MG: Microgranulated formulation and Resid HC: Wettable powder) to cover also row crops (like maize, wheat, etc.) for seed treatment”. The main driver of the Biogard growth strategy is to implement the product portfolio not only in the market segment of microbial biopesticides, but also in other areas where ecological solutions are available”